The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

AMPLATZER Muscular Ventricular Septal Occluder in transcatheter occlusion of the left main coronary artery in a patient with a huge aneurysm secondary to Kawasaki disease

EuroIntervention 2019;15:642-643. DOI: 10.4244/EIJ-D-19-00058

1. Koc University Hospital, Istanbul, Turkey; 2. VKV American Hospital, İstanbul, Turkey




Figure 1. Fluoroscopic images. A) Coronary angiogram showing the aneurysm (a) and dissection (d). B) Aortogram showing the device (*) deployed.

Chronic coronary aneurysms are present in 6% of patients with Kawasaki disease (KD) and are associated with long-term morbidity and mortality1,2. There are several interventional treatment options for coronary aneurysms3. Herein we report the first successful use of transcatheter occlusion of a huge left main coronary artery (LMCA) aneurysm due to KD with an AMPLATZER™ Muscular Ventricular Septal Occluder device (VSO; St. Jude Medical, St. Paul, MN, USA).

The 16-year-old male patient with previous history of KD ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Double-layer bare metal stents in the treatment of coronary artery aneurysm: experience and outcomes in nine patients